Hepatitis E Virus Entry

被引:30
|
作者
Yin, Xin [1 ,3 ]
Feng, Zongdi [1 ,2 ]
机构
[1] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
[3] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, Immun & Pathogenesis Program, La Jolla, CA 92037 USA
来源
VIRUSES-BASEL | 2019年 / 11卷 / 10期
关键词
quasienveloped virus; receptor; lysosomal acid lipase; NPC1; RIBAVIRIN TREATMENT FAILURE; ENTERS LIVER-CELLS; ORF3; PROTEIN; VIRAL-HEPATITIS; CULTURED-CELLS; HEV; INFECTION; PATHOGENESIS; REPLICATION; INTERACTS;
D O I
10.3390/v11100883
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis E virus (HEV) infection is a major cause of acute hepatitis worldwide. It is transmitted enterically but replicates in the liver. Recent studies indicate that HEV exists in two forms: naked, nonenveloped virions that are shed into feces to mediate inter-host transmission, and membrane-cloaked, quasienveloped virions that circulate in the bloodstream to mediate virus spread within a host. Both virion types are infectious, but differ in the way they infect cells. Elucidating the entry mechanism for both virion types is essential to understand HEV biology and pathogenesis, and is relevant to the development of treatments and preventions for HEV. This review summarizes the current understanding of the cell entry mechanism for these two HEV virion types.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Molecular Biology and Infection of Hepatitis E Virus
    Nan, Yuchen
    Zhang, Yan-Jin
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [32] The hepatitis E virus RNA regulatory elements
    Parvez, Mohammad K.
    FUTURE VIROLOGY, 2019, 14 (07) : 445 - 448
  • [33] Hepatitis E Virus; An Underestimated Threat for the Viral Hepatitis Elimination Program
    Pourkarim, Mahmoud Reza
    HEPATITIS MONTHLY, 2022, 22 (01)
  • [34] Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins
    Kalemera, Mphatso D.
    Capella-Pujol, Joan
    Chumbe, Ana
    Underwood, Alexander
    Bull, Rowena A.
    Schinkel, Janke
    Sliepen, Kwinten
    Grove, Joe
    JOURNAL OF GENERAL VIROLOGY, 2021, 102 (01)
  • [35] Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy
    Zhao, Qinjian
    Zhang, Jun
    Wu, Ting
    Li, Shao-Wei
    Ng, Mun-Hon
    Xia, Ning-Shao
    Shih, James Wai-Kuo
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (02) : 159 - 168
  • [36] Full coding hepatitis E virus genotype 3 genome amplification method
    Munoz-Chimeno, M.
    Forero, J. E.
    Echevarria, J. M.
    Munoz-Bellido, J. L.
    Vazquez-Lopez, L.
    Morago, L.
    Garcia-Galera, M. C.
    Avellon, A.
    JOURNAL OF VIROLOGICAL METHODS, 2016, 230 : 18 - 23
  • [37] Prevention of virus hepatitis A to E
    Cornberg, M.
    Manns, M. P.
    INTERNIST, 2011, 52 (03): : 250 - +
  • [38] Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding
    Liu, Shufeng
    McCormick, Kevin D.
    Zhao, Wentao
    Zhao, Ting
    Fan, Daping
    Wang, Tianyi
    HEPATOLOGY, 2012, 56 (02) : 484 - 491
  • [39] Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication
    Florimond, Alexandre
    Chouteau, Philippe
    Bruscella, Patrice
    Le Seyec, Jacques
    Merour, Emilie
    Ahnou, Nazim
    Mallat, Ariane
    Lotersztajn, Sophie
    Pawlotsky, Jean-Michel
    GUT, 2015, 64 (06) : 957 - 965
  • [40] Ankyrin Repeat Domain 1 is Up-regulated During Hepatitis C Virus Infection and Regulates Hepatitis C Virus Entry
    Than, Thoa T.
    Tran, Giao V. Q.
    Son, Kidong
    Park, Eun-Mee
    Kim, Seungtaek
    Lim, Yun-Sook
    Hwang, Soon B.
    SCIENTIFIC REPORTS, 2016, 6